Targeting Alzheimer’s disease with a Geroscience approach

Martin Darvas, PhD; Associate Professor, Neuropathology

Department of Laboratory Medicine and Pathology

University of Washington

Why Attend this Seminar? 

Alzheimer’s disease (AD) is an age-related disease and is expected to increase with the number of elderly individuals rapidly rising in both developed and developing countries. Pharmacological efforts to find disease-modifying treatments have met with limited success possibly because they have focused on identifying a specific drug that targets a specific mechanism. AD is a complex disease involving numerous mechanisms in line with processes of biological aging. In this seminar, the findings from using a cocktail of three drugs with established anti-aging effects in mouse models of AD and AD risk will be reviewed.

Sign-In & Evaluation Form Online: https://forms.gle/dfmHNTVdxH9Dbwbt9

Sign-in is required for students registered in PATH 520. All other attendees are encouraged to track attendance and complete an evaluation of the presentation.